{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:46:54Z","timestamp":1780451214722,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41409-018-0180-y","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T11:13:43Z","timestamp":1524482023000},"page":"1214-1217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet\u2019s disease and secondary myelodysplastic syndrome"],"prefix":"10.1038","volume":"53","author":[{"given":"Maiko","family":"Noguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Moritake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiyo","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoshi","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"180_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2141.2009.07863.x","volume":"147","author":"S Takagi","year":"2009","unstructured":"Takagi S, Masuoka K, Uchida N, Ishiwata K, Araoka H, Tsuji M, et al. High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. Br J Haematol. 2009;147:543\u201353.","journal-title":"Br J Haematol"},{"key":"180_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/sj.bmt.1703554","volume":"29","author":"Y Abe","year":"2002","unstructured":"Abe Y, Choi I, Hara K, Matsushima T, Nishimura J, Inaba S, et al. Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:799\u2013801.","journal-title":"Bone Marrow Transplant"},{"key":"180_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/sj.bmt.1705783","volume":"40","author":"H Ishida","year":"2007","unstructured":"Ishida H, Yoshida H, Yoshihara T, Ito M, Morimoto A. Origin of macrophages involved in the development of allogeneic hematopoietic stem cell transplantation-associated hemophagocytic syndrome: observations on a patient with juvenile myelomonocytic leukemia. Bone Marrow Transplant. 2007;40:701\u20133.","journal-title":"Bone Marrow Transplant"},{"key":"180_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/bmt.2013.145","volume":"49","author":"R Kobayashi","year":"2014","unstructured":"Kobayashi R, Tanaka J, Hashino S, Ota S, Torimoto Y, Kakinoki Y, et al. Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT. Bone Marrow Transplant. 2014;49:254\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"180_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ajh.20462","volume":"81","author":"T Henzan","year":"2006","unstructured":"Henzan T, Nagafuji K, Tsukamoto H, Miyamoto T, Gondo H, Imashuku S, et al. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006;81:59\u201361.","journal-title":"Am J Hematol"},{"key":"180_CR6","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/rheumatology\/kem205","volume":"46","author":"H Ideguchi","year":"2007","unstructured":"Ideguchi H, Ohno S, Takase K, Hattori H, Kirino Y, Takeno M, et al. Successful treatment of refractory lupus-associated haemophagocytic lymphohisitiocytosis with infliximab. Rheumatology. 2007;46:1621\u20132.","journal-title":"Rheumatology"},{"key":"180_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/pbc.21019","volume":"50","author":"B Makay","year":"2008","unstructured":"Makay B, Yilmaz S, T\u00fcrkyilmaz Z, Unal N, Oren H, Unsal E. Etanercept for therapy-resistant macrophage activation syndrome. Pediatr Blood Cancer. 2008;50:419\u201321.","journal-title":"Pediatr Blood Cancer"},{"key":"180_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"180_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/pbc.22774","volume":"56","author":"TF Lin","year":"2011","unstructured":"Lin TF, Ferlic-Stark LL, Allen CE, Kozinetz CA, McClain KL. Rate of decline of ferritin in patients with hemophagocytic lymphohisitiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer. 2011;56:154\u20135.","journal-title":"Pediatr Blood Cancer"},{"key":"180_CR10","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Campigotto F, Mullally A, Fogerty A, Massarotti E, Neuberg D, et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015;125:1548\u201352.","journal-title":"Blood"},{"key":"180_CR11","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1182\/blood-2003-01-0267","volume":"102","author":"FM Marty","year":"2003","unstructured":"Marty FM, Lee SJ, Fahey MM, Alyea EP, Soiffer RJ, Antin JH, et al. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood. 2003;102:2768\u201376.","journal-title":"Blood"},{"key":"180_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1182\/blood-2003-12-4241","volume":"104","author":"D Couriel","year":"2004","unstructured":"Couriel D, Saliba R, Hicks K, Ippoliti C, de Lima M, Hosing C, et al. Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood. 2004;104:649\u201354.","journal-title":"Blood"},{"key":"180_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ajh.20752","volume":"82","author":"A Busca","year":"2007","unstructured":"Busca A, Locatelli F, Marmont F, Ceretto C, Falda M. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2007;82:45\u201352.","journal-title":"Am J Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0180-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0180-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:58Z","timestamp":1684617118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0180-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["180"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0180-y","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}